BIOMARIN PHARMACEUTICAL INC Asset Retirement Obligation, Period Increase (Decrease)
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Asset Retirement Obligation, Period Increase (Decrease) of -$1.07 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationPeriodIncreaseDecrease · last filed 2015-03-02
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for the quarter ending 2014-12-31 was -$34.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for the quarter ending 2014-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for the quarter ending 2014-06-30 was -$739.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for the quarter ending 2014-03-31 was -$302.00K.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for fiscal 2014 was -$1.07M, a 1294.44% decline from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC asset retirement obligation, period increase (decrease) for fiscal 2013 was $90.00K.
| Period end | Asset Retirement Obligation, Period Increase (Decrease) 3 month | Asset Retirement Obligation, Period Increase (Decrease) 6 month | Asset Retirement Obligation, Period Increase (Decrease) 9 month | Asset Retirement Obligation, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$34.00K derived: sum of 2 quarters · filed 2015-03-02 | -$773.00K derived: sum of 3 quarters · filed 2015-03-02 | -$1.07M 10-K · filed 2015-03-02 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$739.00K derived: sum of 2 quarters · filed 2014-10-28 | -$1.04M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | -$739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$1.04M 10-Q · filed 2014-07-31 | ||
| 2014-03-31 | -$302.00K 10-Q · filed 2014-05-02 | |||
| 2013-12-31 | $90.00K 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |